Multiple sclerosis: Neuroprotective alliance of estrogen-progesterone and gender

Frontiers in Neuroendocrinology

Volumn 33, Issue 1, 2012, Pages 1-16

  Kipp, Markus ^a,b   Amor, Sandra ^b,c   Krauth, Raphael ^a   Beyer, Cordian ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Axon; Estrogen; Inflammation; Multiple sclerosis; Myelin; Neuroprotection; Oligodendrocyte; Progesterone; Remyelination

Indexed keywords

AROMATASE; BETA1A INTERFERON; CRK ASSOCIATED SUBSTRATE PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FINGOLIMOD; GLATIRAMER; GLUTAMIC ACID; INTERFERON BETA SERINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOXANTRONE; MNAR PROTEIN; MODULATOR OF NONGENOMIC ACTION OF ESTROGEN RECEPTOR; MYELIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NATALIZUMAB; NERVE GROWTH FACTOR; PELP1 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; PROGESTERONE RECEPTOR; PROLINE GLUTAMIC ACID AND LEUCINE RICH PROTEIN 1; PROTEIN; RECOMBINANT BETA INTERFERON; RIBIF; SEX HORMONE; STRIATIN; UNCLASSIFIED DRUG;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; APOPTOSIS; ASTROCYTE; BRAIN DEVELOPMENT; CELL INTERACTION; CELL SURVIVAL; COGNITIVE DEFECT; DEMYELINATION; DRUG MECHANISM; ESTROGEN SYNTHESIS; GENDER; HIPPOCAMPUS; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MICROGLIA; MITOCHONDRION; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVE CELL DIFFERENTIATION; NERVE CELL LESION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; REMYELINIZATION; REVIEW; SEX DIFFERENCE; SEX RATIO; STEROIDOGENESIS; TRANSCRIPTION REGULATION;

ANIMALS; BRAIN; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; PROGESTERONE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEX FACTORS;

EID: 84857359521     PISSN: 00913022     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.yfrne.2012.01.001     Document Type: Review

References (235)

1. Acconcia F., Ascenzi P., Fabozzi G., Visca P., Marino M. S-palmitoylation modulates human estrogen receptor-alpha functions. Biochem. Biophys. Res. Commun. 2004, 316:878-883.
2. Acs P., Kipp M., Norkute A., Johann S., Clarner T., Braun A., Berente Z., Komoly S., Beyer C. 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 2009, 57:807-814.
3. Agresti C., Meomartini M.E., Amadio S., Ambrosini E., Volonte C., Aloisi F., Visentin S. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors. Brain Res. Brain Res. Rev. 2005, 48:157-165.
4. Alkayed N.J., Goto S., Sugo N., Joh H.D., Klaus J., Crain B.J., Bernard O., Traystman R.J., Hurn P.D. Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J. Neurosci. 2001, 21:7543-7550.
5. Amantea D., Russo R., Bagetta G., Corasaniti M.T. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol. Res. 2005, 52:119-132.
6. Araujo G.W., Beyer C., Arnold S. Oestrogen influences on mitochondrial gene expression and respiratory chain activity in cortical and mesencephalic astrocytes. J. Neuroendocrinol. 2008, 20:930-941.
7. Arevalo M.A., Santos-Galindo M., Bellini M.J., Azcoitia I., Garcia-Segura L.M. Actions of estrogens on glial cells: implications for neuroprotection. Biochim. Biophys. Acta 1800, 2010:1106-1112.
8. Arnold S., Beyer C. Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. J. Neurochem. 2009, 110:1-11.
9. Arnold S., de Araujo G.W., Beyer C. Gender-specific regulation of mitochondrial fusion and fission gene transcription and viability of cortical astrocytes by steroid hormones. J. Mol. Endocrinol. 2008, 41:289-300.
10. Arnoult D., Soares F., Tattoli I., Girardin S.E. Mitochondria in innate immunity. EMBO Rep. 2011, 12:901-910.
11. Arvanitis D.N., Wang H., Bagshaw R.D., Callahan J.W., Boggs J.M. Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes. J. Neurosci. Res. 2004, 75:603-613.
12. Back S.A., Tuohy T.M., Chen H., Wallingford N., Craig A., Struve J., Luo N.L., Banine F., Liu Y., Chang A., Trapp B.D., Bebo B.F., Rao M.S., Sherman L.S. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 2005, 11:966-972.
13. Baker A.E., Brautigam V.M., Watters J.J. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 2004, 145:5021-5032.
14. Balthazart J., Ball G.F. New insights into the regulation and function of brain estrogen synthase (aromatase). Trends Neurosci. 1998, 21:243-249.
15. Barnett M.H., Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 2004, 55:458-468.
16. Beato M., Herrlich P., Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995, 83:851-857.
17. Beck K.D., Powell-Braxton L., Widmer H.R., Valverde J., Hefti F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 1995, 14:717-730.
18. Behl C. Oestrogen as a neuroprotective hormone. Nat. Rev. Neurosci. 2002, 3:433-442.
19. Bettini E., Maggi A. Estrogen induction of cytochrome c oxidase subunit III in rat hippocampus. J. Neurochem. 1992, 58:1923-1929.
20. Beyer C. Estrogen and the developing mammalian brain. Anat. Embryol. (Berl) 1999, 199:379-390.
21. Beyer C., Green S.J., Hutchison J.B. Androgens influence sexual differentiation of embryonic mouse hypothalamic aromatase neurons in vitro. Endocrinology 1994, 135:1220-1226.
22. Beyer C., Pawlak J., Karolczak M. Membrane receptors for oestrogen in the brain. J. Neurochem. 2003, 87:545-550.
23. Beyer C., Raab H. Nongenomic effects of oestrogen: embryonic mouse midbrain neurones respond with a rapid release of calcium from intracellular stores. Eur. J. Neurosci. 1998, 10:255-262.
24. Blurton-Jones M., Tuszynski M.H. Reactive astrocytes express estrogen receptors in the injured primate brain. J. Comp. Neurol. 2001, 433:115-123.
25. Boon W.C., Chow J.D., Simpson E.R. The multiple roles of estrogens and the enzyme aromatase. Prog. Brain Res. 2010, 181:209-232.
26. Brinkmann V., Billich A., Baumruker T., Heining P., Schmouder R., Francis G., Aradhye S., Burtin P. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 2010, 9:883-897.
27. Brinton R.D., Thompson R.F., Foy M.R., Baudry M., Wang J., Finch C.E., Morgan T.E., Pike C.J., Mack W.J., Stanczyk F.Z., Nilsen J. Progesterone receptors: form and function in brain. Front. Neuroendocrinol. 2008, 29:313-339.
28. Bruce-Keller A.J., Keeling J.L., Keller J.N., Huang F.F., Camondola S., Mattson M.P. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 2000, 141:3646-3656.
29. Buck D., Hemmer B. Treatment of multiple sclerosis: current concepts and future perspectives. J. Neurol. 2011, 258:1747-1762.
30. Bunge M.B., Williams A.K., Wood P.M. Neuron-Schwann cell interaction in basal lamina formation. Dev. Biol. 1982, 92:449-460.
31. Burris T.P., Krishnan V. Estrogen: a mitochondrial energizer that keeps on going. Mol. Pharmacol. 2005, 68:956-958.
32. Cabodi S., Moro L., Baj G., Smeriglio M., Di Stefano P., Gippone S., Surico N., Silengo L., Turco E., Tarone G., Defilippi P. P130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. J. Cell Sci. 2004, 117:1603-1611.
33. Callard G.V., Petro Z., Ryan K.J. Aromatization of androgen to estrogen by cultured turtle brain cells. Brain Res. 1980, 202:117-130.
34. Campbell G.R., Ziabreva I., Reeve A.K., Krishnan K.J., Reynolds R., Howell O., Lassmann H., Turnbull D.M., Mahad D.J. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann. Neurol. 2011, 69:481-492.
35. Cantarella G., Risuglia N., Lombardo G., Lempereur L., Nicoletti F., Memo M., Bernardini R. Protective effects of estradiol on TRAIL-induced apoptosis in a human oligodendrocytic cell line: evidence for multiple sites of interactions. Cell Death Differ. 2004, 11:503-511.
36. Cardona-Gomez G.P., Mendez P., DonCarlos L.L., Azcoitia I., Garcia-Segura L.M. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res. Brain Res. Rev. 2001, 37:320-334.
37. Carrer H.F., Cambiasso M.J. Sexual differentiation of the brain: genes, estrogen, and neurotrophic factors. Cell. Mol. Neurobiol. 2002, 22:479-500.
38. Caruso D., D'Intino G., Giatti S., Maschi O., Pesaresi M., Calabrese D., Garcia-Segura L.M., Calza L., Melcangi R.C. Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis. J. Neurochem. 2010, 114:921-932.
39. Chakrabarty A., Blacklock A., Svojanovsky S., Smith P.G. Estrogen elicits dorsal root ganglion axon sprouting via a renin-angiotensin system. Endocrinology 2008, 149:3452-3460.
40. Chan J.R., Phillips L.J., Glaser M. Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc. Natl. Acad. Sci. USA 1998, 95:10459-10464.
41. Chang A., Tourtellotte W.W., Rudick R., Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 2002, 346:165-173.
42. Charalampopoulos I., Remboutsika E., Margioris A.N., Gravanis A. Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol. Metab. 2008, 19:300-307.
43. Chen S., Nilsen J., Brinton R.D. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology 2006, 147:5303-5313.
44. Chesik D., De Keyser J. Progesterone and dexamethasone differentially regulate the IGF-system in glial cells. Neurosci. Lett. 2010, 468:178-182.
45. Cheskis B.J., Greger J.G., Nagpal S., Freedman L.P. Signaling by estrogens. J. Cell. Physiol. 2007, 213:610-617.
46. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med. 1998, 339:285-291.
47. Cossburn M., Ingram G., Hirst C., Ben-Shlomo Y., Pickersgill T., Robertson N. Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Mult. Scler. 2011.
48. Crawford D.K., Mangiardi M., Song B., Patel R., Du S., Sofroniew M.V., Voskuhl R.R., Tiwari-Woodruff S.K. Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain 2010, 133:2999-3016.
49. Curry J.J., Heim L.M. Brain myelination after neonatal administration of oestradiol. Nature 1966, 209:915-916.
50. Cyr M., Ghribi O., Thibault C., Morissette M., Landry M., Di Paolo T. Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors. Brain Res. Brain Res. Rev. 2001, 37:153-161.
51. Czlonkowska A., Ciesielska A., Gromadzka G., Kurkowska-Jastrzebska I. Estrogen and cytokines production - the possible cause of gender differences in neurological diseases. Curr. Pharm. Des. 2005, 11:1017-1030.
52. Dang J., Mitkari B., Kipp M., Beyer C. Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav. Immun. 2011, 25:715-726.
53. Diaz H., Lorenzo A., Carrer H.F., Caceres A. Time lapse study of neurite growth in hypothalamic dissociated neurons in culture: sex differences and estrogen effects. J. Neurosci. Res. 1992, 33:266-281.
54. Drew P.D., Chavis J.A. Female sex steroids: effects upon microglial cell activation. J. Neuroimmunol. 2000, 111:77-85.
55. Du S., Sandoval F., Trinh P., Umeda E., Voskuhl R. Estrogen receptor-beta ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease. Eur. J. Immunol. 2011, 41:140-150.
56. Einheber S., Zanazzi G., Ching W., Scherer S., Milner T.A., Peles E., Salzer J.L. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J. Cell Biol. 1997, 139:1495-1506.
57. Fazekas F., Enzinger C., Wallner-Blazek M., Ropele S., Pluta-Fuerst A., Fuchs S. Gender differences in MRI studies on multiple sclerosis. J. Neurol. Sci. 2009, 286:28-30.
58. Feeser V.R., Loria R.M. Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions. J. Neuroimmunol. 2011, 237:4-12.
59. Fester L., Prange-Kiel J., Jarry H., Rune G.M. Estrogen synthesis in the hippocampus. Cell Tissue Res. 2011, 345:285-294.
60. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
61. Fok-Seang J., Mathews G.A., ffrench-Constant C., Trotter J., Fawcett J.W. Migration of oligodendrocyte precursors on astrocytes and meningeal cells. Dev. Biol. 1995, 171:1-15.
62. Franklin R.J., Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9:839-855.
63. Frye C.A. The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res. Brain Res. Rev. 2001, 37:201-222.
64. Gago N., Akwa Y., Sananes N., Guennoun R., Baulieu E.E., El-Etr M., Schumacher M. Progesterone and the oligodendroglial lineage: stage-dependent biosynthesis and metabolism. Glia 2001, 36:295-308.
65. Galbiati M., Magnaghi V., Martini L., Melcangi R.C. Hypothalamic transforming growth factor beta1 and basic fibroblast growth factor mRNA expression is modified during the rat oestrous cycle. J. Neuroendocrinol. 2001, 13:483-489.
66. Garay L., Gonzalez Deniselle M.C., Gierman L., Meyer M., Lima A., Roig P., De Nicola A.F. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 2008, 15:76-83.
67. Garcia-Ovejero D., Veiga S., Garcia-Segura L.M., Doncarlos L.L. Glial expression of estrogen and androgen receptors after rat brain injury. J. Comp. Neurol. 2002, 450:256-271.
68. Gatson J.W., Simpkins J.W., Yi K.D., Idris A.H., Minei J.P., Wigginton J.G. Aromatase is increased in astrocytes in the presence of elevated pressure. Endocrinology 2011, 152:207-213.
69. Gavrilova-Jordan L.P., Price T.M. Actions of steroids in mitochondria. Semin. Reprod. Med. 2007, 25:154-164.
70. Gegelashvili G., Schousboe A. High affinity glutamate transporters: regulation of expression and activity. Mol. Pharmacol. 1997, 52:6-15.
71. Gerstner B., Lee J., DeSilva T.M., Jensen F.E., Volpe J.J., Rosenberg P.A. 17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J. Neurosci. Res 2009, 87:2078-2086.
72. Gerstner B., Sifringer M., Dzietko M., Schuller A., Lee J., Simons S., Obladen M., Volpe J.J., Rosenberg P.A., Felderhoff-Mueser U. Estradiol attenuates hyperoxia-induced cell death in the developing white matter. Ann. Neurol. 2007, 61:562-573.
73. Geurts J.J., Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol. 2008, 7:841-851.
74. Geurts J.J., Stys P.K., Minagar A., Amor S., Zivadinov R. Gray matter pathology in (chronic) MS: modern views on an early observation. J. Neurol. Sci. 2009, 282:12-20.
75. Ghoumari A.M., Baulieu E.E., Schumacher M. Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 2005, 135:47-58.
76. Ghoumari A.M., Ibanez C., El-Etr M., Leclerc P., Eychenne B., O'Malley B.W., Baulieu E.E., Schumacher M. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 2003, 86:848-859.
77. Giretti M.S., Simoncini T. Rapid regulatory actions of sex steroids on cell movement through the actin cytoskeleton. Steroids 2008, 73:895-900.
78. Gitsch, Reitinger J. The effects of exogenic hormones on the acetylcholine content of the rat's central hypothalamus; the influence of natural and synthetic estrogens and of progesterone on the hypothalamic acetylcholine content. I. Zentralbl Gynakol 1953, 75:209-218.
79. Gocke A.R., Hussain R.Z., Yang Y., Peng H., Weiner J., Ben L.H., Drew P.D., Stuve O., Lovett-Racke A.E., Racke M.K. Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease. J. Immunol. 2009, 182:4479-4487.
80. Gold S.M., Voskuhl R.R. Estrogen and testosterone therapies in multiple sclerosis. Prog. Brain Res. 2009, 175:239-251.
81. Gollapudi L., Oblinger M.M. Estrogen effects on neurite outgrowth and cytoskeletal gene expression in ERalpha-transfected PC12 cell lines. Exp. Neurol. 2001, 171:308-316.
82. Gonez L.J., Naselli G., Banakh I., Niwa H., Harrison L.C. Pancreatic expression and mitochondrial localization of the progestin-adipoQ receptor PAQR10. Mol. Med. 2008, 14:697-704.
83. Gonzalez Deniselle M.C., Gonzalez S.L., De Nicola A.F. Cellular basis of steroid neuroprotection in the wobbler mouse, a genetic model of motoneuron disease. Cell. Mol. Neurobiol. 2001, 21:237-254.
84. Gu Q., Moss R.L. 17 beta-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J. Neurosci. 1996, 16:3620-3629.
85. Guennoun R., Benmessahel Y., Delespierre B., Gouezou M., Rajkowski K.M., Baulieu E.E., Schumacher M. Progesterone stimulates Krox-20 gene expression in Schwann cells. Brain Res. Mol. Brain Res. 2001, 90:75-82.
86. Guennoun R., Meffre D., Labombarda F., Gonzalez S.L., Deniselle M.C., Stein D.G., De Nicola A.F., Schumacher M. The membrane-associated progesterone-binding protein 25-Dx: expression, cellular localization and up-regulation after brain and spinal cord injuries. Brain Res. Rev. 2008, 57:493-505.
87. Guttinger H.R., Herth G., Stocker S., Kafitz K.W., Kallenbach M. Antioestrogen inhibits myelination in brains of juvenile Zebra finches. Neuroreport 1993, 4:1019-1022.
88. Hager G.L., Lim C.S., Elbi C., Baumann C.T. Trafficking of nuclear receptors in living cells. J. Steroid Biochem. Mol. Biol. 2000, 74:249-254.
89. Halliday A.M. Visual evoked potentials in demyelinating disease. Adv. Neurol. 1981, 31:201-215.
90. Hamilton N.B., Attwell D. Do astrocytes really exocytose neurotransmitters?. Nat. Rev. Neurosci. 2010, 11:227-238.
91. Hentges S., Boyadjieva N., Sarkar D.K. Transforming growth factor-beta3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 2000, 141:859-867.
92. Hermann A., Brandt M.D., Loewenbruck K.F., Storch A. " Silenced" polydendrocytes: a new cell type within the oligodendrocyte progenitor cell population?. Cell Tissue Res. 2010, 340:45-50.
93. Hesse A., Wagner M., Held J., Bruck W., Salinas-Riester G., Hao Z., Waisman A., Kuhlmann T. In toxic demyelination oligodendroglial cell death occurs early and is FAS independent. Neurobiol. Dis. 2010, 37:362-369.
94. Hirahara Y., Matsuda K., Gao W., Arvanitis D.N., Kawata M., Boggs J.M. The localization and non-genomic function of the membrane-associated estrogen receptor in oligodendrocytes. Glia 2009, 57:153-165.
95. Hoffman G.E., Le W.W., Murphy A.Z., Koski C.L. Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats. Exp. Neurol. 2001, 171:272-284.
96. Hua K., Forbes M.E., Lichtenwalner R.J., Sonntag W.E., Riddle D.R. Adult-onset deficiency in growth hormone and insulin-like growth factor-I alters oligodendrocyte turnover in the corpus callosum. Glia 2009, 57:1062-1071.
97. Ibanez C., Shields S.A., El-Etr M., Baulieu E.E., Schumacher M., Franklin R.J. Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol. Appl. Neurobiol. 2004, 30:80-89.
98. Irvine K.A., Blakemore W.F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 2008, 131:1464-1477.
99. Ivanova T., Karolczak M., Beyer C. Estradiol stimulates GDNF expression in developing hypothalamic neurons. Endocrinology 2002, 143:3175-3178.
100. Ivanova T., Kuppers E., Engele J., Beyer C. Estrogen stimulates brain-derived neurotrophic factor expression in embryonic mouse midbrain neurons through a membrane-mediated and calcium-dependent mechanism. J. Neurosci. Res. 2001, 66:221-230.
101. Ivanova T., Mendez P., Garcia-Segura L.M., Beyer C. Rapid stimulation of the PI3-kinase/Akt signalling pathway in developing midbrain neurones by oestrogen. J. Neuroendocrinol. 2002, 14:73-79.
102. Jakobkiewicz-Banecka J., Wegrzyn A., Wegrzyn G. Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases. J. Appl. Genet. 2007, 48:383-388.
103. Jha S., Srivastava S.Y., Brickey W.J., Iocca H., Toews A., Morrison J.P., Chen V.S., Gris D., Matsushima G.K., Ting J.P. The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J. Neurosci. 2010, 30:15811-15820.
104. Johann S., Dahm M., Kipp M., Beyer C., Arnold S. Oestrogen regulates mitochondrial respiratory chain enzyme transcription in the mouse spinal cord. J. Neuroendocrinol. 2010, 22:926-935.
105. Johnson E.S., Ludwin S.K. The demonstration of recurrent demyelination and remyelination of axons in the central nervous system. Acta Neuropathol. 1981, 53:93-98.
106. Jung-Testas I., Renoir M., Bugnard H., Greene G.L., Baulieu E.E. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J. Steroid Biochem. Mol. Biol. 1992, 41:621-631.
107. Kajta M., Beyer C. Cellular strategies of estrogen-mediated neuroprotection during brain development. Endocrine 2003, 21:3-9.
108. Kajta M., Budziszewska B., Marszal M., Lason W. Effects of 17-beta estradiol and estriol on NMDA-induced toxicity and apoptosis in primary cultures of rat cortical neurons. J. Physiol. Pharmacol. 2001, 52:437-446.
109. Kappos L., Bates D., Edan G., Eraksoy M., Garcia-Merino A., Grigoriadis N., Hartung H.P., Havrdova E., Hillert J., Hohlfeld R., Kremenchutzky M., Lyon-Caen O., Miller A., Pozzilli C., Ravnborg M., Saida T., Sindic C., Vass K., Clifford D.B., Hauser S., Major E.O., O'Connor P.W., Weiner H.L., Clanet M., Gold R., Hirsch H.H., Radu E.W., Sorensen P.S., King J. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol. 2011, 10:745-758.
110. Kappos L., Radue E.W., O'Connor P., Polman C., Hohlfeld R., Calabresi P., Selmaj K., Agoropoulou C., Leyk M., Zhang-Auberson L., Burtin P. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 2010, 362:387-401.
111. Karolczak M., Kuppers E., Beyer C. Developmental expression and regulation of aromatase- and 5alpha-reductase type I mRNA in the male and female mouse hypothalamus. J. Neuroendocrinol. 1998, 10:267-274.
112. Keirstead H.S., Levine J.M., Blakemore W.F. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 1998, 22:161-170.
113. Kelly M.J., Moss R.L., Dudley C.A. Differential sensitivity of preoptic-septal neurons to microelectrophoresed estrogen during the estrous cycle. Brain Res. 1976, 114:152-157.
114. Kim H.J., Casadesus G. Estrogen-mediated effects on cognition and synaptic plasticity: what do estrogen receptor knockout models tell us?. Biochim. Biophys. Acta 1800, 2010:1090-1093.
115. Kipp M., Berger K., Clarner T., Dang J., Beyer C. Sex steroids control neuroinflammatory processes in the brain: relevance for acute ischemia and degenerative demyelination. J. Neuroendocrinol. 2011.
116. Kipp M., Beyer C. Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Front. Neuroendocrinol. 2009, 30:188-200.
117. Kipp M., Clarner T., Dang J., Copray S., Beyer C. The cuprizone animal model: new insights into an old story. Acta Neuropathol. 2009, 118:723-736.
118. Kipp M., Karakaya S., Johann S., Kampmann E., Mey J., Beyer C. Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factor-alpha and interleukin-18 in midbrain astrocytes. J. Neuroendocrinol. 2007, 19:819-822.
119. Klein R.S., Izikson L., Means T., Gibson H.D., Lin E., Sobel R.A., Weiner H.L., Luster A.D. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis. J. Immunol. 2004, 172:550-559.
120. Koenig H.L., Schumacher M., Ferzaz B., Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268:1500-1503.
121. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., Linington C., Schmidbauer M., Lassmann H. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 2000, 157:267-276.
122. Kuhlmann T., Goldschmidt T., Antel J., Wegner C., Konig F., Metz I., Bruck W. Gender differences in the histopathology of MS?. J. Neurol. Sci. 2009, 286:86-91.
123. Kuo J., Hamid N., Bondar G., Prossnitz E.R., Micevych P. Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes. J. Neurosci. 2010, 30:12950-12957.
124. Kuppers E., Krust A., Chambon P., Beyer C. Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO) mice. Psychoneuroendocrinology 2008, 33:832-838.
125. Labombarda F., Gonzalez S., Gonzalez Deniselle M.C., Garay L., Guennoun R., Schumacher M., De Nicola A.F. Progesterone increases the expression of myelin basic protein and the number of cells showing NG2 immunostaining in the lesioned spinal cord. J. Neurotrauma 2006, 23:181-192.
126. Labombarda F., Gonzalez S.L., Lima A., Roig P., Guennoun R., Schumacher M., de Nicola A.F. Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia 2009, 57:884-897.
127. Lassmann H. Multiple sclerosis pathology: evolution of pathogenetic concepts. Brain Pathol. 2005, 15:217-222.
128. Lassmann H. Models of multiple sclerosis: new insights into pathophysiology and repair. Curr. Opin. Neurol. 2008, 21:242-247.
129. Leake J.A., Albani S., Kao A.S., Senac M.O., Billman G.F., Nespeca M.P., Paulino A.D., Quintela E.R., Sawyer M.H., Bradley J.S. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr. Infect. Dis. J. 2004, 23:756-764.
130. Leranth C., Hajszan T., Szigeti-Buck K., Bober J., MacLusky N.J. Bisphenol A prevents the synaptogenic response to estradiol in hippocampus and prefrontal cortex of ovariectomized nonhuman primates. Proc. Natl. Acad. Sci. USA 2008, 105:14187-14191.
131. Liang Z., Valla J., Sefidvash-Hockley S., Rogers J., Li R. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J. Neurochem. 2002, 80:807-814.
132. Lincoln D.W. Unit activity in the hypothalamus, septum and preoptic area of the rat: characteristics of spontaneous activity and the effect of oestrogen. J. Endocrinol. 1967, 37:177-189.
133. Liu L., Darnall L., Hu T., Choi K., Lane T.E., Ransohoff R.M. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J. Neurosci. 2010, 30:9074-9083.
134. Liu Y., Hao W., Letiembre M., Walter S., Kulanga M., Neumann H., Fassbender K. Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J. Neurosci. 2006, 26:12904-12913.
135. Lorenz L., Dang J., Misiak M., Tameh Abolfazl A., Beyer C., Kipp M. Combined 17beta-oestradiol and progesterone treatment prevents neuronal cell injury in cortical but not midbrain neurones or neuroblastoma cells. J. Neuroendocrinol. 2009, 21:841-849.
136. Lu Q., Pallas D.C., Surks H.K., Baur W.E., Mendelsohn M.E., Karas R.H. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc. Natl. Acad. Sci. USA 2004, 101:17126-17131.
137. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707-717.
138. MacLusky N.J., Naftolin F. Sexual differentiation of the central nervous system. Science 1981, 211:1294-1302.
139. Mahad D.J., Ziabreva I., Campbell G., Lax N., White K., Hanson P.S., Lassmann H., Turnbull D.M. Mitochondrial changes within axons in multiple sclerosis. Brain 2009, 132:1161-1174.
140. Marik C., Felts P.A., Bauer J., Lassmann H., Smith K.J. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?. Brain 2007, 130:2800-2815.
141. Marin-Husstege M., Muggironi M., Raban D., Skoff R.P., Casaccia-Bonnefil P. Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev. Neurosci. 2004, 26:245-254.
142. Marriott J.J., Miyasaki J.M., Gronseth G., O'Connor P.W. Evidence report: the efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2011, 74:1463-1470.
143. Mason J.L., Jones J.J., Taniike M., Morell P., Suzuki K., Matsushima G.K. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 2000, 61:251-262.
144. Mattingly K.A., Ivanova M.M., Riggs K.A., Wickramasinghe N.S., Barch M.J., Klinge C.M. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol. Endocrinol. 2008, 22:609-622.
145. McCarthy M.M. How it's made: organisational effects of hormones on the developing brain. J. Neuroendocrinol. 2010, 22:736-742.
146. McEwen B.S., Davis P.G., Parsons B., Pfaff D.W. The brain as a target for steroid hormone action. Annu. Rev. Neurosci. 1979, 2:65-112.
147. McEwen B.S., Lieberburg I., Chaptal C., Krey L.C. Aromatization: important for sexual differentiation of the neonatal rat brain. Horm. Behav. 1977, 9:249-263.
148. Menge T., Hemmer B., Nessler S., Wiendl H., Neuhaus O., Hartung H.P., Kieseier B.C., Stuve O. Acute disseminated encephalomyelitis: an update. Arch. Neurol. 2005, 62:1673-1680.
149. Mermelstein P.G., Becker J.B., Surmeier D.J. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J. Neurosci. 1996, 16:595-604.
150. Munding C., Keller M., Niklaus G., Papin S., Tschopp J., Werner S., Beer H.D. The estrogen-responsive B box protein: a novel enhancer of interleukin-1beta secretion. Cell Death Differ. 2006, 13:1938-1949.
151. Muneoka K., Kuwagata M., Ogawa T., Shioda S. Sex-specific effects of early neonatal progesterone treatment on dopamine and serotonin metabolism in rat striatum and frontal cortex. Life Sci. 2010, 87:738-742.
152. Mydlarski M.B., Liberman A., Schipper H.M. Estrogen induction of glial heat shock proteins: implications for hypothalamic aging. Neurobiol. Aging 1995, 16:977-981.
153. Navarro C.E., Saeed S.A., Murdock C., Martinez-Fuentes A.J., Arora K.K., Krsmanovic L.Z., Catt K.J. Regulation of cyclic adenosine 3',5'-monophosphate signaling and pulsatile neurosecretion by Gi-coupled plasma membrane estrogen receptors in immortalized gonadotrophin-releasing hormone neurons. Mol. Endocrinol. 2003, 17:1792-1804.
154. Nicholas R.S., Wing M.G., Compston A. Nonactivated microglia promote oligodendrocyte precursor survival and maturation through the transcription factor NF-kappa B. Eur. J. Neurosci. 2001, 13:959-967.
155. Nilsen J., Diaz Brinton R. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc. Natl. Acad. Sci. USA 2003, 100:2842-2847.
156. Noorbakhsh F., Ellestad K.K., Maingat F., Warren K.G., Han M.H., Steinman L., Baker G.B., Power C. Impaired neurosteroid synthesis in multiple sclerosis. Brain 2011, 134:2703-2721.
157. Nunez J.L., McCarthy M.M. Sex differences and hormonal effects in a model of preterm infant brain injury. Ann. N. Y. Acad. Sci. 2003, 1008:281-284.
158. Okada M., Makino A., Nakajima M., Okuyama S., Furukawa S., Furukawa Y. Estrogen stimulates proliferation and differentiation of neural stem/progenitor cells through different signal transduction pathways. Int. J. Mol. Sci. 2010, 11:4114-4123.
159. Ozturk A., Smith S.A., Gordon-Lipkin E.M., Harrison D.M., Shiee N., Pham D.L., Caffo B.S., Calabresi P.A., Reich D.S. MRI of the corpus callosum in multiple sclerosis: association with disability. Mult. Scler. 2010, 16:166-177.
160. Pawlak J., Karolczak M., Krust A., Chambon P., Beyer C. Estrogen receptor-alpha is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway. Glia 2005, 50:270-275.
161. Penderis J., Shields S.A., Franklin R.J. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 2003, 126:1382-1391.
162. Pike C.J. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 1999, 72:1552-1563.
163. Platania P., Laureanti F., Bellomo M., Giuffrida R., Giuffrida-Stella A.M., Catania M.V., Sortino M.A. Differential expression of estrogen receptors alpha and beta in the spinal cord during postnatal development: localization in glial cells. Neuroendocrinology 2003, 77:334-340.
164. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the " McDonald Criteria" Ann. Neurol. 2005, 58(2005):840-846.
165. Pomata P.E., Colman-Lerner A.A., Baranao J.L., Fiszman M.L. In vivo evidences of early neurosteroid synthesis in the developing rat central nervous system and placenta. Brain Res. Dev. Brain Res. 2000, 120:83-86.
166. Pozzilli C., Tomassini V., Marinelli F., Paolillo A., Gasperini C., Bastianello S. 'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence. Eur. J. Neurol. 2003, 10:95-97.
167. Prayer D., Roberts T., Barkovich A.J., Prayer L., Kucharczyk J., Moseley M., Arieff A. Diffusion-weighted MRI of myelination in the rat brain following treatment with gonadal hormones. Neuroradiology 1997, 39:320-325.
168. Puder J.J., Freda P.U., Goland R.S., Wardlaw S.L. Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. J. Clin. Endocrinol. Metab. 2001, 86:2403-2408.
169. Quadros P.S., Pfau J.L., Wagner C.K. Distribution of progesterone receptor immunoreactivity in the fetal and neonatal rat forebrain. J. Comp. Neurol. 2007, 504:42-56.
170. Raab H., Beyer C., Wozniak A., Hutchison J.B., Pilgrim C., Reisert I. Ontogeny of aromatase messenger ribonucleic acid and aromatase activity in the rat midbrain. Brain Res. Mol. Brain Res. 1995, 34:333-336.
171. Racke M.K., Lovett-Racke A.E., Karandikar N.J. The mechanism of action of glatiramer acetate treatment in multiple sclerosis. Neurology 2010, 74(Suppl 1):S25-S30.
172. Raff M.C., Miller R.H., Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 1983, 303:390-396.
173. Ramagopalan S.V., Link J., Byrnes J.K., Dyment D.A., Giovannoni G., Hintzen R.Q., Sundqvist E., Kockum I., Smestad C., Lie B.A., Harbo H.F., Padyukov L., Alfredsson L., Olsson T., Sadovnick A.D., Hillert J., Ebers G.C. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 2009, 73:2107-2111.
174. Raz L., Khan M.M., Mahesh V.B., Vadlamudi R.K., Brann D.W. Rapid estrogen signaling in the brain. Neurosignals 2008, 16:140-153.
175. Razmara A., Duckles S.P., Krause D.N., Procaccio V. Estrogen suppresses brain mitochondrial oxidative stress in female and male rats. Brain Res. 2007, 1176:71-81.
176. Reed J.L., Dimayuga F.O., Davies L.M., Keller J.N., Bruce-Keller A.J. Estrogen increases proteasome activity in murine microglial cells. Neurosci. Lett. 2004, 367:60-65.
177. Reynolds R., Dawson M., Papadopoulos D., Polito A., Di Bello I.C., Pham-Dinh D., Levine J. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J. Neurocytol. 2002, 31:523-536.
178. Rissman E.F., Wersinger S.R., Taylor J.A., Lubahn D.B. Estrogen receptor function as revealed by knockout studies: neuroendocrine and behavioral aspects. Horm. Behav. 1997, 31:232-243.
179. Rozovsky I., Wei M., Stone D.J., Zanjani H., Anderson C.P., Morgan T.E., Finch C.E. Estradiol (E2) enhances neurite outgrowth by repressing glial fibrillary acidic protein expression and reorganizing laminin. Endocrinology 2002, 143:636-646.
180. Rucker B., Pochmann D., Furstenau C.R., Carneiro-Ramos M.S., Battastini A.M., Barreto-Chaves M.L., Sarkis J.J. Effects of steroid hormones on synaptosomal ectonucleotidase activities from hippocampus and cortex of adult female rats. Gen. Comp. Endocrinol. 2005, 140:94-100.
181. Rudick R.A., Goelz S.E. Beta-interferon for multiple sclerosis. Exp. Cell Res. 2011, 317:1301-1311.
182. Sakamoto H., Ukena K., Tsutsui K. Effects of progesterone synthesized de novo in the developing Purkinje cell on its dendritic growth and synaptogenesis. J. Neurosci. 2001, 21:6221-6232.
183. Santagati S., Melcangi R.C., Celotti F., Martini L., Maggi A. Estrogen receptor is expressed in different types of glial cells in culture. J. Neurochem. 1994, 63:2058-2064.
184. Saunders-Pullman R. Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?. Endocrine 2003, 21:81-87.
185. Sayeed I., Stein D.G. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog. Brain Res. 2009, 175:219-237.
186. M.M. Schoonheim, H.E. Hulst, D. Landi, O. Ciccarelli, S.D. Roosendaal, E.J. Sanz-Arigita, H. Vrenken, C.H. Polman, C.J. Stam, F. Barkhof, J.J. Geurts, Gender-related differences in functional connectivity in multiple sclerosis, Mult. Scler. (2011).
187. Schumacher M., Guennoun R., Mercier G., Desarnaud F., Lacor P., Benavides J., Ferzaz B., Robert F., Baulieu E.E. Progesterone synthesis and myelin formation in peripheral nerves. Brain Res. Brain Res. Rev. 2001, 37:343-359.
188. Schumacher M., Sitruk-Ware R., De Nicola A.F. Progesterone and progestins: neuroprotection and myelin repair. Curr. Opin. Pharmacol. 2008, 8:740-746.
189. Sicotte N.L., Liva S.M., Klutch R., Pfeiffer P., Bouvier S., Odesa S., Wu T.C., Voskuhl R.R. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol. 2002, 52:421-428.
190. Sierra A., Gottfried-Blackmore A., Milner T.A., McEwen B.S., Bulloch K. Steroid hormone receptor expression and function in microglia. Glia 2008, 56:659-674.
191. Simon J.H., Jacobs L.D., Campion M., Wende K., Simonian N., Cookfair D.L., Rudick R.A., Herndon R.M., Richert J.R., Salazar A.M., Alam J.J., Fischer J.S., Goodkin D.E., Granger C.V., Lajaunie M., Martens-Davidson A.L., Meyer M., Sheeder J., Choi K., Scherzinger A.L., Bartoszak D.M., Bourdette D.N., Braiman J., Brownscheidle C.M., Whitham R.H., et al. Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The multiple sclerosis collaborative research group. Ann. Neurol. 1998, 43:79-87.
192. Simpson J.E., Newcombe J., Cuzner M.L., Woodroofe M.N. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 2000, 26:133-142.
193. Smejkalova T., Woolley C.S. Estradiol acutely potentiates hippocampal excitatory synaptic transmission through a presynaptic mechanism. J. Neurosci. 2010, 30:16137-16148.
194. Smith E.J., Blakemore W.F., McDonald W.I. Central remyelination restores secure conduction. Nature 1979, 280:395-396.
195. Smith J.A., Das A., Butler J.T., Ray S.K., Banik N.L. Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death. Neurochem. Res. 2011, 36:1587-1593.
196. Smith R., Studd J.W. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J. R. Soc. Med. 1992, 85:612-613.
197. Sohrabji F., Lewis D.K. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front. Neuroendocrinol. 2006, 27:404-414.
198. Spence R.D., Hamby M.E., Umeda E., Itoh N., Du S., Wisdom A.J., Cao Y., Bondar G., Lam J., Ao Y., Sandoval F., Suriany S., Sofroniew M.V., Voskuhl R.R. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc. Natl. Acad. Sci. USA 2011, 108:8867-8872.
199. Takao T., Flint N., Lee L., Ying X., Merrill J., Chandross K.J. 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J. Neurochem. 2004, 89:660-673.
200. Tapia-Gonzalez S., Carrero P., Pernia O., Garcia-Segura L.M., Diz-Chaves Y. Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs. J. Endocrinol. 2008, 198:219-230.
201. Taylor L.C., Puranam K., Gilmore W., Ting J.P., Matsushima G.K. 17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss. Neurobiol. Dis. 2010, 39:127-137.
202. Thrower B.W. Clinically isolated syndromes: predicting and delaying multiple sclerosis. Neurology 2007, 68:S12-S15.
203. Tintore M., Arrambide G. Early onset multiple sclerosis: the role of gender. J. Neurol. Sci. 2009, 286:31-34.
204. Tiwari-Woodruff S., Morales L.B., Lee R., Voskuhl R.R. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc. Natl. Acad. Sci. USA 2007, 104:14813-14818.
205. Tiwari-Woodruff S., Voskuhl R.R. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. J. Neurol. Sci. 2009, 286:81-85.
206. Toran-Allerand C.D., Ellis L., Pfenninger K.H. Estrogen and insulin synergism in neurite growth enhancement in vitro: mediation of steroid effects by interactions with growth factors?. Brain Res. 1988, 469:87-100.
207. Toran-Allerand C.D., Hashimoto K., Greenough W.T., Saltarelli M. Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro: III. Effects of estrogen on dendritic differentiation. Brain Res. 1983, 283:97-101.
208. Torisu H., Kira R., Ishizaki Y., Sanefuji M., Yamaguchi Y., Yasumoto S., Murakami Y., Shimono M., Nagamitsu S., Masuzaki M., Amamoto M., Kondo R., Uozumi T., Aibe M., Gondo K., Hanai T., Hirose S., Matsuishi T., Shirahata A., Mitsudome A., Hara T. Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev. 2010, 32:454-462.
209. Tsuruo Y., Ishimura K., Fujita H., Osawa Y. Immunocytochemical localization of aromatase-containing neurons in the rat brain during pre- and postnatal development. Cell Tissue Res. 1994, 278:29-39.
210. Tsutsui K. Progesterone biosynthesis and action in the developing neuron. Endocrinology 2008, 149:2757-2761.
211. van der Valk P., Amor S. Preactive lesions in multiple sclerosis. Curr. Opin. Neurol. 2009, 22:207-213.
212. van der Valk P., De Groot C.J. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol. Appl. Neurobiol. 2000, 26:2-10.
213. Van der Walt A., Butzkueven H., Kolbe S., Marriott M., Alexandrou E., Gresle M., Egan G., Kilpatrick T. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade. Pharmacol. Ther. 2010, 126:82-93.
214. van Noort J.M., Bsibsi M., Gerritsen W.H., van der Valk P., Bajramovic J.J., Steinman L., Amor S. Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 2010, 69:694-703.
215. van Noort J.M., van den Elsen P.J., van Horssen J., Geurts J.J., van der Valk P., Amor S. Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. CNS Neurol. Disord. Drug Targets 2011, 10:68-81.
216. Vanderluit J.L., Bourque J.A., Peterson A.C., Tetzlaff W. Model for focal demyelination of the spinal dorsal columns of transgenic MBP-LacZ mice by phototargeted ablation of oligodendrocytes. J. Neurosci. Res. 2000, 62:28-39.
217. Vasudevan N., Pfaff D.W. Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front. Neuroendocrinol. 2008, 29:238-257.
218. Verdru P., Theys P., D'Hooghe M.B., Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg 1994, 96:38-41.
219. Voskuhl R.R. Hormone-based therapies in MS. Int. MS J. 2003, 10:60-66.
220. Vukusic S., Ionescu I., El-Etr M., Schumacher M., Baulieu E.E., Cornu C., Confavreux C. The prevention of post-partum relapses with progestin and estradiol in multiple sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J. Neurol. Sci. 2009, 286:114-118.
221. Wang J.M., Johnston P.B., Ball B.G., Brinton R.D. The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J. Neurosci. 2005, 25:4706-4718.
222. Wang K.K., Larner S.F., Robinson G., Hayes R.L. Neuroprotection targets after traumatic brain injury. Curr. Opin. Neurol. 2006, 19:514-519.
223. Wen Y., Yang S., Liu R., Perez E., Yi K.D., Koulen P., Simpkins J.W. Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res. 2004, 1008:147-154.
224. Whitacre C.C., Reingold S.C., O'Looney P.A. A gender gap in autoimmunity. Science 1999, 283:1277-1278.
225. Wingerchuk D.M. Neuromyelitis optica: effect of gender. J. Neurol Sci. 2009, 286:18-23.
226. Wong C.W., McNally C., Nickbarg E., Komm B.S., Cheskis B.J. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc. Natl. Acad. Sci. USA 2002, 99:14783-14788.
227. Wong M., Thompson T.L., Moss R.L. Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms. Crit. Rev. Neurobiol. 1996, 10:189-203.
228. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., Liao F., Checler F., Buxbaum J.D., Chait B.T., Thinakaran G., Sisodia S.S., Wang R., Greengard P., Gandy S. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 1998, 4:447-451.
229. Yanase M., Honmura A., Akaishi T., Sakuma Y. Nerve growth factor-mediated sexual differentiation of the rat hypothalamus. Neurosci. Res. 1988, 6:181-185.
230. Yates M.A., Li Y., Chlebeck P., Proctor T., Vandenbark A.A., Offner H. Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2010, 220:136-139.
231. Young N.P., Weinshenker B.G., Lucchinetti C.F. Acute disseminated encephalomyelitis: current understanding and controversies. Semin. Neurol. 2008, 28:84-94.
232. Zambonin J.L., Zhao C., Ohno N., Campbell G.R., Engeham S., Ziabreva I., Schwarz N., Lee S.E., Frischer J.M., Turnbull D.M., Trapp B.D., Lassmann H., Franklin R.J., Mahad D.J. Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis. Brain 2011, 134:1901-1913.
233. Zhu T.S., Glaser M. Neuroprotection and enhancement of remyelination by estradiol and dexamethasone in cocultures of rat DRG neurons and Schwann cells. Brain Res. 2008, 1206:20-32.
234. Zhu W., Wiggins R.C., Konat G.W. Glucocorticoid-induced upregulation of proteolipid protein and myelin-associated glycoprotein genes in C6 cells. J. Neurosci. Res. 1994, 37:208-212.
235. Zwain I.H., Yen S.S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 1999, 140:3843-3852.